This brand name is authorized in Spain, France, Romania, Tunisia, United Kingdom
The drug STREPSILS VITAMINE C contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Ascorbic acid
UNII PQ6CK8PD0R - ASCORBIC ACID
|
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
|
2
Sodium ascorbate
UNII S033EH8359 - SODIUM ASCORBATE
|
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
|
3
Amylmetacresol
UNII 05W904P57F - AMYLMETACRESOL
|
|
Amylmetacresol is an antibacterial and antiviral agent, and blocks voltage-gated Na channels in a local anesthetic-like manner. It relieves symptoms of sore throat/irritation of the throat. Amylmetacresol is thought to inhibit the inflammatory and pain mediators that are involved in the inflammation of the mouth and throat mucous membranes, as well as the sore throat. |
|
4
Dichlorobenzyl alcohol
UNII 1NKX3648J9 - DICHLOROBENZYL ALCOHOL
|
|
Dichlorobenzyl alcohol has antiseptic properties. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R02AA03 | Dichlorobenzyl alcohol | R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 57193 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 63530827 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 119361 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66081001, W66081002 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 10673021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
